IP Library Granted Patent US 10,266,503
Granted Patent B1
US 10,266,503 · App. 15/604,377 · Granted Apr 23, 2019

Sulfoxide ligand metal catalyzed oxidation of olefins

Inventors: M. Christina White (Champaign, IL); Stephen E. Ammann (Champaign, IL); Wei Liu (Simi Valley, CA); Rulin Ma (Urbana, IL)
Assignee: The Board of Trustees of the University of Illinois
C07D263/10C07C317/14C07B2200/07
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,266,503
App. No.
15/604,377
Granted
Apr 23, 2019
Kind
B1
Abstract

The enantioselective synthesis of isochroman motifs has been accomplished via Pd(II)-catalyzed allylic C—H oxidation from terminal olefin precursors. Critical to the success of this goal was the development and utilization of a novel chiral aryl sulfoxide-oxazoline (ArSOX) ligand. The allylic C—H oxidation reaction proceeds with the broadest scope and highest levels asymmetric induction reported to date (avg. 92% ee, 13 examples ≥90% ee). Additionally, C(sp 3 )-N fragment coupling reaction between abundant terminal olefins and N-triflyl protected aliphatic and aromatic amines via Pd(II)/sulfoxide (SOX) catalyzed intermolecular allylic C—H amination is disclosed. A range of 52 allylic amines are furnished in good yields (avg. 76%) and excellent regio- and stereoselectivity (avg. >20:1 linear:branched, >20:1 E:Z). For the first time, a variety of singly activated aromatic and aliphatic nitrogen nucleophiles, including ones with stereochemical elements, can be used in fragment coupling stiochiometries for intermolecular C—H amination reactions.

Claims (59)

1. A compound of Formula I:

wherein

R a is H, alkyl, heteroalkyl, cycloalkyl, heterocycle, aryl, or heteroaryl;

R b is alkyl, heteroalkyl, cycloalkyl, heterocycle, aryl, or heteroaryl;

Q is alkyl, heteroalkyl, cycloalkyl, heterocycle, heteroaryl, phenanthryl, 2-naphthyl, 1-naphthyl provided that R 1 , R 2 , R 3 , or R 4 is not H, or Q is the moiety Q1:

R 1 , R 2 , R 3 , R 4 , A 1 , A 2 , A 4 , and A 5 are each independently H, halo, alkyl, heteroalkyl, trifluoromethyl, trifluoromethoxy, OR x , N(R x ) 2 , nitro, cycloalkyl, aryl, or heteroaryl;

A 3 is H, halo, (C 3 -C 8 )alkyl, a heteroalkyl, a trifluoromethyl, trifluoromethoxy, OR x , N(R x ) 2 , nitro, cycloalkyl, aryl, or heteroaryl; and

each R x is independently H, (C 1 -C 8 )alkyl, or benzyl;

wherein at least one of R a and R b is cycloalkyl, heterocycle, aryl, or heteroaryl.

2. The compound of claim 1 wherein the sulfoxide moiety is in the (S)-configuration and the R a —C—R b moiety is in the (S)-configuration or in the (R)-configuration.

3. The compound of claim 1 wherein the sulfoxide moiety is in the (R)-configuration and the R a —C—R b moiety is in the (S)-configuration, or in the (R)-configuration.

4. The compound of claim 1 wherein:

R a is H, (C 1 -C 8 )alkyl, heteroalkyl, (C 3 -C 8 )cycloalkyl, or phenyl, wherein phenyl is optionally substituted with 1-5 substituents J;

R b is (C 1 -C 8 )alkyl, heteroalkyl, (C 3 -C 8 )cycloalkyl, or phenyl, wherein phenyl is optionally substituted with 1-5 substituents J;

Q is (C 1 -C 8 )alkyl, heteroalkyl, (C 3 -C 8 )cycloalkyl, or Q1;

R 1 , R 2 , R 3 , R 4 , A 1 , A 2 , A 4 and A 5 are each independently H, halo, (C 1 -C 8 )alkyl, trifluoromethyl, trifluoromethoxy, OR x , N(R x ) 2 , nitro, (C 3 -C 8 )cycloalkyl, or phenyl, wherein phenyl is optionally substituted with 1-5 substituents J;

A 3 is H, halo, (C 3 -C 8 )alkyl, trifluoromethyl, trifluoromethoxy, OR x , N(R x ) 2 , nitro, (C 3 -C 8 )cycloalkyl, or phenyl, wherein phenyl is optionally substituted with 1-5 substituents J; and

each J is independently H, halo, (C 1 -C 8 )alkyl, trifluoromethyl, trifluoromethoxy, OR x , N(R x ) 2 , nitro, or (C 3 -C 8 )cycloalkyl.

5. The compound of claim 4 wherein:

R a is H, methyl, ethyl, n-propyl, 2-propyl, cyclopropyl, n-butyl, tert-butyl, iso-butyl, cyclopentyl, cyclohexyl, phenyl, p-tolyl, 4-methoxyphenyl, 4-trifluoromethylphenyl, or 4-trifluoromethoxyphenyl; and

R b is methyl, ethyl, n-propyl, 2-propyl, cyclopropyl, n-butyl, tert-butyl, iso-butyl, cyclopentyl, cyclohexyl, phenyl, p-tolyl, 4-methoxyphenyl, 4-trifluoromethylphenyl, 4-trifluoromethoxyphenyl, 4-tert-butylphenyl, 4-tert-butoxylphenyl, 3,4,5-trimethoxylphenyl, or 3,5-di-tert-butyl-4-methoxyphenyl.

6. The compound of claim 4 wherein Q is isopropyl, cyclohexyl, 4-methylcyclohexyl, phenyl, 4-bromophenyl, 4-methoxyphenyl, 4-trifluoromethylphenyl, 4-trifluoromethoxyphenyl, 4-tert-butylphenyl, 4-tert-butoxylphenyl, 3,5-dimethylphenyl, 3,5-di-tert-butyl-4-methoxyphenyl, or 9-phenanthryl.

7. The compound of claim 4 wherein R 1 , R 2 , R 3 , R 4 , A 1 , A 2 , A 4 and A 5 are each independently fluoro, chloro, bromo, methyl, ethyl, 2-propyl, tert-butyl, cyclopropyl, cyclopentyl, cyclohexyl, trifluoromethoxy, nitro, trifluoromethyl, pentafluoroethyl, OR x , or N(R x ) 2 ;

A 3 is fluoro, chloro, bromo, ethyl, 2-propyl, tert-butyl, cyclopropyl, cyclopentyl, cyclohexyl, trifluoromethoxy, nitro, trifluoromethyl, pentafluoroethyl, OR x , or N(R x ) 2 ; and

each R x is independently H, methyl, ethyl, n-propyl, iso-propyl, cyclopropyl, n-butyl, sec-butyl, tert-butyl, or benzyl.

8. The compound of claim 1 wherein the compound of Formula I is a compound of Formula II:

wherein

R b is (C 3 -C 8 )cycloalkyl, or phenyl, wherein phenyl is optionally substituted with 1-5 substituents J;

R 1 , R 2 , R 3 , R 4 , A 1 , A 2 , A 4 and A 5 are each independently H, halo, (C 1 -C 8 )alkyl, trifluoromethyl, trifluoromethoxy, OR x , N(R x ) 2 , nitro, (C 3 -C 8 )cycloalkyl, or phenyl, wherein phenyl is optionally substituted with 1-5 substituents J;

A 3 is H, halo, (C 3 -C 8 )alkyl, trifluoromethyl, trifluoromethoxy, OR x , N(R x ) 2 , nitro, (C 3 -C 8 )cycloalkyl, or phenyl, wherein phenyl is optionally substituted with 1-5 substituents J;

each J is independently H, halo, (C 1 -C 8 )alkyl, trifluoromethyl, trifluoromethoxy, OR x , N(R x ) 2 , nitro, or (C 3 -C 8 )cycloalkyl; and

the H—C—R b moiety is in the (S)-configuration and the sulfoxide moiety is in the (R)-configuration, or the H—C—R b moiety is in the (R)-configuration and the sulfoxide moiety is in the (S)-configuration.

9. The compound of claim 8 wherein the compound of Formula II is a compound of Formula III:

wherein

R 2 , R 3 , A 2 , A 4 , A 6 , A 7 , A 8 , and A 9 are each independently H, halo, (C 1 -C 8 )alkyl, trifluoromethyl, trifluoromethoxy, OR x , N(R x ) 2 , nitro, (C 3 -C 8 )cycloalkyl, or phenyl, wherein phenyl is optionally substituted with 1-5 substituents J;

A 3 is H, halo, (C 3 -C 8 )alkyl, trifluoromethyl, OR x , trifluoromethoxy, N(R x ) 2 , nitro, (C 3 -C 8 )cycloalkyl, or phenyl, wherein phenyl is optionally substituted with 1-5 substituents J;

each J is independently H, halo, (C 1 -C 8 )alkyl, trifluoromethyl, OR x , trifluoromethoxy, N(R x ) 2 , nitro, or (C 3 -C 8 )cycloalkyl; and

the dihydrooxazole moiety is in the (S)-configuration at position-4 and the sulfoxide moiety is in the (R)-configuration, or the dihydrooxazole moiety is in the (R)-configuration at position-4 and the sulfoxide moiety is in the (S)-configuration.

10. The compound of claim 1 wherein the compound is a compound of Formula IIA:

wherein R 9 is methoxy, t-butyl, or trifluoromethoxy.

11. The compound:

12. A compound of Formula IB:

wherein

R a is alkyl, heteroalkyl, cycloalkyl, heterocycle, aryl, or heteroaryl;

R b is alkyl, heteroalkyl, cycloalkyl, heterocycle, aryl, or heteroaryl;

Q is alkyl, heteroalkyl, cycloalkyl, heterocycle, heteroaryl, phenanthryl, 2-naphthyl, 1-naphthyl provided that R 1 , R 2 , R 3 , or R 4 is not H, or Q is the moiety Q1:

R 1 , R 2 , R 3 , R 4 , A 1 , A 2 , A 4 , and A 5 are each independently H, halo, alkyl, heteroalkyl, trifluoromethyl, trifluoromethoxy, OR x , N(R x ) 2 , nitro, cycloalkyl, aryl, or heteroaryl;

A 3 is H, halo, (C 2 -C 8 )alkyl, a heteroalkyl, a trifluoromethyl, trifluoromethoxy, OR x , N(R x ) 2 , nitro, cycloalkyl, aryl, heteroaryl, or methyl; and

each R x is independently H, (C 1 -C 8 )alkyl, or benzyl.

13. The compound of claim 12 wherein the compound of Formula I is a compound of Formula IV:

wherein

R a and R b are each independently methyl, ethyl, n-propyl, 2-propyl, cyclopropyl, tert-butyl, iso-butyl, cyclopentyl, cyclohexyl, phenyl, 4-tolyl, 4-methoxyphenyl, 4-trifluoromethylphenyl, or 4-trifluoromethoxyphenyl;

R 2 , R 3 , A 2 , A 3 , and A 4 are each independently, H, fluoro, chloro, bromo, methyl, ethyl, 2-propyl, tert-butyl, cyclopropyl, cyclopentyl, cyclohexyl, trifluoromethoxy, nitro, trifluoromethyl, pentafluoroethyl, OR x , or N(R x ) 2 ; and

each R x is independently H, methyl, ethyl, n-propyl, iso-propyl, cyclopropyl, n-butyl, sec-butyl, tert-butyl, or benzyl.

14. The compound of claim 13 wherein the compound is a compound of Formula IVA:

wherein

R 11 and R 12 are each independently H, methoxy, trifluoromethyl, or trifluoromethoxy;

R 13 is methyl or phenyl; and

R 14 is methyl, methoxy, or phenyl.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2017
From: WHITE, M. CHRISTINA; AMMANN, STEPHEN E.; LIU, WEI; MA, RULIN
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
Reel/Frame 043840/0677 →
CONFIRMATORY LICENSE Recorded Jun 14, 2017
From: UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 042806/0805 →
Continuity (1)
Provisional Application 62340909 · May 24, 2016